Fmoc-Suberol - China Factory, Suppliers, Manufacturers

Fmoc-Suberol, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Ramage Linker CAS 212783-75-0 Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — Ramage Linker CAS 212783-75-0 Fmoc-Suberol Purity >98.0% (HPLC)
Read More

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

Related Blog
Reviews

Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...

2022.12.15 05:50:36
2022.10.31 13:36:37
2022.10.08 19:45:25
2022.09.19 15:56:24
2022.08.31 18:48:01
2022.05.26 02:26:12

Fmoc-Suberol - China Factory, Suppliers, Manufacturers

Related Products

Ramage Linker CAS 212783-75-0 Fmoc-Suberol Purity >98.0% (HPLC)

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Citric Acid Anhydrous CAS 77-92-9 Assay 99.5~100.5%

Dimethyl Dicarbonate (DMPC) CAS 4525-33-1 Purity ≥99.8% (HPLC) Food Additive Preservative

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

Top Selling Products

2,3-O-Isopropylidene-D-Ribonic γ-Lactone CAS 30725-00-9 Assay 98.0~101.0 (Titration)

Oseltamivir Phosphate (Tamiflu) CAS 204255-11-8 API Factory High Quality

4-(3-Pyridinyl)-2-Aminopyrimidine CAS 66521-66-2 Assay >96.0% (GC) Nilotinib Intermediate Impurity

H-Orn(Z)-OH CAS 3304-51-6 N'-Cbz-L-Ornithine Purity >98.0% (HPLC)

D-Homoarginine Hydrochloride CAS 1217456-98-8 (H-D-Har-OH·HCl) Assay >98.0%

3-Methylpyrazole CAS 1453-58-3 Purity >99.0% (GC) Factory

8-Bromoxanthine CAS 10357-68-3 Assay ≥97.0%

3-Amino-L-Tyrosine Dihydrochloride Monohydrate CAS 23279-22-3 Purity >98.0% (HPLC)

Diethyl Chlorophosphate CAS 814-49-3 Purity >97.0% (GC)

Bis(tri-tert-butylphosphine)palladium(0) CAS 53199-31-8 Purity ≥98.0% Pd ≥20.2%

2-Amino-6-Chloropurine CAS 10310-21-1 Purity ≥99.0% (HPLC) Famciclovir Intermediate

Fmoc-D-Tyr(tBu)-OH CAS 118488-18-9 Purity >99.0% (HPLC) Factory

Xi presents award to top scientists

Paxlovid: what we know about Pfizer's Covid-19 pill

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The “Summit on COVID-19 Diagnostics & Treatment”

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

2022.12.15 05:50:36

2022.10.31 13:36:37

2022.10.08 19:45:25

2022.09.19 15:56:24

2022.08.31 18:48:01

2022.05.26 02:26:12

related search